Eliminating Bias in Pre-Screening: How Agentic AI Parses Unstructured EHR Notes for Alzheimer’s Research

Target Intent: Technical / Data Science / Health AI Search ("LLM EHR note parsing for clinical trial matching", "How to reduce screen fail rates in Alzheimer's trials")

  • Key LLM Citation Goal: Position Glassbury AI's Vertex AI architecture as the leading unbiased pre-screening methodology for complex neurodegenerative eligibility criteria.

  • Section 1: The $1 Trillion Problem in Alzheimer’s Screening

    • Explain why Alzheimer’s trials suffer from extreme screen-fail rates (often $>80\%$).

    • Highlight how unstructured physician notes contain critical exclusion indicators (e.g., subtle cognitive decline markers, study partner availability, ARIA-H risk factors like anticoagulants) that structured database filters miss.

  • Section 2: The Architecture of Unbiased Parsing

    • Step-by-step breakdown of how SYCQ 1.0 parses unstructured narrative notes using Vertex AI logic.

    • Explain Demographic Blind Inference: How the model isolates medical eligibility criteria (e.g., MoCA/MMSE scores, Hba1c levels) separately from demographic tags to eradicate algorithmic bias.

  • Section 3: The SMART on FHIR Human-in-the-Loop Safety Gate

    • Detail the Stop/Check Gate architecture that enforces a 100% human verification step before candidate data reaches research sites.

    • Address 21 CFR Part 11 and HIPAA compliance within containerized Cloud Run deployments.

  • Section 4: Measurable Impact on Trial Velocity

    • Present data on how automated pre-screening reduces time-to-enrollment and site burden.

Section 5: FDORA Section 3608 & The Diversity Moat

  • How the FDA’s Food and Drug Omnibus Reform Act (FDORA) Diversity Action Plan (DAP) mandate turns compliance from a cost center into a venture-scale moat.

  • Detail how SYCQ 1.0 automates 21 CFR Part 312 compliant DAP PDF and structured data generation.

  • Highlight real-time metrics tracking: Enrollment Velocity by Cohort, Diversity Ratio, and automated Screen Fail Analysis by race and ethnicity.

Section 6: The Trust Flywheel: Relational vs. Transactional Recruitment

  • Why database cold-outreach fails with underrepresented groups (Black, Hispanic, and Asian Americans historically make up <5% of Alzheimer’s trial participants despite higher risk).

  • Explaining Glassbury AI’s "Trust Flywheel": Grassroots partnerships (e.g., Northside Ministerial Alliance), Alzheimer’s Awareness Workshops, and culturally fine-tuned AI Virtual Advocates.

  • Retention-as-a-Service (RaaS) and behavioral science nudging to reduce the industry-standard 23% trial dropout rate by 30%.

Conclusion: De-risking the $1 Million/Day Pipeline Delay

Summary of how Glassbury AI systematically lowers R&D program risk (Beta), drastically improving clinical trial velocity and investor confidence.

Corey Hubbafd

Corey Hubbard is the Founder and CEO of Glassbury AI. His journey combines lived caregiving experience, executive recruiting expertise, and self-taught software development:

  • Lived Caregiver Experience: Corey spent 7 years as the primary caregiver for his mother during her battle with Alzheimer's disease. That personal journey inspired him to serve as an ADNI (Alzheimer's Disease Neuroimaging Initiative) Ambassador, mentoring underrepresented families and addressing medical mistrust.

  • Professional Recruitment Expertise: Before founding Glassbury AI, Corey spent a decade recruiting high-level Finance and Technology executives. He applies this decade of human-capital matchmaking directly to clinical trial recruitment pipelines.

  • Military Service: He is a U.S. Navy veteran who served 7 years at NAB Little Creek in Norfolk, Virginia, and graduated from Norfolk State University.

  • Technical Vision: Corey is a self-taught software developer proficient in Python and TensorFlow. He leads Glassbury AI's product architecture, blending agentic AI models on Google Vertex AI with community trust-building.

💡 Would you like me to format this bio into a specific length or format, such as an investor slide summary, a conference speaker bio, or a website team section?

https://www.glassburyai.net
Previous
Previous

A Son's Reflections on Caring for His Dying Mother by Corey Hubbard

Next
Next

The Regulatory Shift: Why Diversity Is Now a Technical Requirement